Abstract Background Thymic epithelial tumors (TETs) are rare malignancies and the
treatment options are limited. We aimed to evaluate the efficacy and safety of apatinib, an …

Simple Summary Thymic carcinoma is identified as thoracic neoplasm having low sensitivity
to systemic chemotherapy. As first-line setting, platinum-based chemotherapy is …

Background The low incidence of thymic carcinoma has precluded the development of
randomized clinical trials, and present knowledge is based on small retrospective studies …

Aims Thymic carcinoma (TC) is a rare form of highly invasive tumors. Currently, the standard
first-line therapy involves paclitaxel plus carboplatin treatment, while the recommended …

Background Squamous cell carcinoma of the thymus is a rare thymic epithelial neoplasm
that tends to widely metastasize at initial presentation. Because of its rarity, the optimal …

Purpose Due to the rarity of thymic epithelial tumors (TET), no standard chemotherapy
regimen has been identified in the relapsed setting. The aim of this study was to investigate …

胸腺瘤是一类具有广谱生物学行为的罕见肿瘤. 对局部晚期胸腺瘤采用新辅助化放疗,
可缩小肿瘤或降低分期, 提高手术完整切除率. 对于无手术指征或远处转移的胸腺瘤给予姑息性 …

Thymic carcinomas are extremely infrequent neoplasms (15% of all thymic epithelial
tumors). Basaloid carcinoma is a peculiar tumor that represents no more than 2% of those …

Tóm tắt Mục tiêu: Đánh giá tỷ lệ đáp ứng, thời gian sống thêm và một số tác dụng không
mong muốn của phác đồ Paclitaxel–Carboplatin trong điều trị bệnh nhân ung thư biểu mô …

Thymoma is a rare tumor with a broad spectrum of biological behavior. For locally advanced
thymoma, neoadjuvant chemoradiotherapy can reduce tumor staging and improve surgical …